knowledge -WSS

knowledge

author：leisure time 2025-09-29 00:34:09 - browse：752

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Reframing the conversation around gain

WSS

Why Marc Tessier

New chart reveals military’s vast involvement in Operation Warp Speed

Neuroscience startup Neumora files for IPO

Appeals court upholds limits to abortion pill

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

hotspot

knowledge

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Hey, doctors: Don't be no

The high cost of giving birth even with insurance

Appeals court upholds limits to abortion pill

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What AAP's gender

Medical leaders decry Supreme Court decision on affirmative action

New chart reveals military’s vast involvement in Operation Warp Speed

The high cost of giving birth even with insurance

CDC advisory panel says seniors 'may' get RSV vaccine

hotspot

What is artificial intelligence? Experts weigh in

Trump Organization, Michael Cohen agree to settle million

As pharma fights Medicare drug negotiation, hospitals, docs silent

Feds fine Medicare Advantage plans for overcharging members

New chief aims to remake Sanofi Genzyme

Why Marc Tessier

hotspot

hotspot

leisure time

Wikipedia